Health policies and research issues regarding refugees and conflict regions

Building the capacity to research health in conflict settings

Editor's Choice for August 2018

New important compounds for targeted and immunotherapies for lung cancer

Updates from a range of lung cancer studies

Five practice changing shifts in oncology

Treating myelodysplastic syndromes

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Rare mutations in non small cell lung cancer

The promise of immunotherapy in head and neck, and prostate cancer

Several important studies for lung cancer